Are­na sheds ties to weight drug Belviq, com­plet­ing a makeover

From now on, you can scratch any lin­ger­ing rep Are­na Phar­ma­ceu­ti­cals $AR­NA had as an obe­si­ty-fo­cused biotech. Four-and-a-half years af­ter the FDA ap­proved its weight …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.